RE: Official Response from Tiziana about trials6 Jun 2021 13:24
Sangijudas1,
Tils are an opportunist organization and that is not a bad thing . Nearly every pharma/biotech tried some molecule against covid and they will also have useful data from those trials .
RE: Official Response from Tiziana about trials5 Jun 2021 22:04
When one does research on biotech companies , one does look at clinical trials US as a major source of information ...
It is great that TILS has clarified some of the issues that you have highlighted so me may now move forward .
The level of communication is sometimes wanting with TILS as they want to move much quicker than the ´ norm ‘ ....
I.e. compassionate use versus clinical trial ..
Cutting corners is acceptable in Covid trials but not in ordinary times ... TILS need to clarify their methods if they don’t want shorters to have a field day with the SP ...imo